DataSheet_1_Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation.docx by Qiang Yu (5487)

“…Besides, we demonstrated that glutamine metabolism blocking inhibited T cells activation and differentiation through decreasing the mRNA expression of amino acid transporter solute carrier family 7 member 5 (SLC7A5) and mitigating the activation of mTOR signaling.…”

Noscapine selectively cause survivin downregulation in SK-SY5Y and LA1-5S cells. by Shiwang Li (313930)

“…<p>Immunoblotting for survivin, cIAP1and XIAP using lysates from SK-SY5Y(A) and LA1-5S (B) cells treated with DMSO (control) or Noscapine (50 µmol/L) for the indicated time periods. …”

DRLE had a direct vasodilatory effect on porcine coronary arterial rings. by Lung-Shuo Wang (3391244)

Table_1_FgVps9, a Rab5 GEF, Is Critical for DON Biosynthesis and Pathogenicity in Fusarium graminearum.doc by Chengdong Yang (3132015)

“…In this study, we have identified and characterized a Rab5 guanine nucleotide exchange factor (GEF), the Vps9 homolog FgVps9, in F. graminearum. …”

Image_5_The Effect of Magnesium Intake on Stroke Incidence: A Systematic Review and Meta-Analysis With Trial Sequential Analysis.TIF by Binghao Zhao (7143560)

E1A recruits hPaf1 to HAdV early gene promoters via hBre1. by Gregory J. Fonseca (421739)

“…A549 cells were infected with WT HAdV, ΔE1A HAdV or HAdV containing deletions within E1A for 20 hours. …”

Image 5_Corynebacteria from the respiratory microbiota modulate inflammatory responses and associate with a reduced pneumococcal burden in the lungs.tif by Caroline Bergenfelz (741819)

A structural variant in the 5’-flanking region of the <i>TWIST2</i> gene affects melanocyte development in belted cattle by Nivedita Awasthi Mishra (4179457)

Image 5_Systematic evaluation of plant metals/metalloids accumulation efficiency: a global synthesis of bioaccumulation and translocation factors.tif by Wenbin Huang (452904)

Cellular localization of APOBEC3 proteins. by Pierre Khalfi (7868252)

Safety assessment of omeprazole use: a review by Marcela Forgerini (6483410)

“…The question guiding the present review was “Which adverse events occur in patients using omeprazole in a Food and Drug Administration-approved and/or off-label manner?” …”

Western blot and mitochondrial network analyses. by Pierre Khalfi (7868252)

Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome by Raffaella De Pace (5147120)

Effect of dot density, dot pattern refresh rate and relative receptive field size on disparity tuning in a model cell. by Sid Henriksen (2795824)

Diet composition and nutritional values. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Nutritional and metabolic analysis. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Cardiovascular parameters. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Baf155 ablation does not affect the stability of components of SWI/SNF complex in the skeletal muscle. by Jong-Seol Kang (14925926)

Water management in a concrete plant: Moringa oleifera employment analysis without wastewater treatment and reuse proposal after treatment by Thaynara de Almeida Corrêa e Silva (6825533)

Inhibition of acetylcholine or cytisine-elicited current in <i>L</i>.<i>stagnalis</i> neurons by PP PLA₂ and β-Bgt. by Catherine A. Vulfius (676708)